Back
Corvus Pharmaceuticals Vs. Meituan Industry Stock Comparison
Buy
58
CRVS
Corvus Pharmaceuticals
Last Price:
5.94
Seasonality Move:
-4.43%
Buy
55
MPNGY
Meituan
Last Price:
48.14
Seasonality Move:
-5.08%
Buy
58
Corvus Pharmaceuticals (CRVS)
is a Buy
Is Corvus Pharmaceuticals a Buy, Sell or Hold?
- The current Corvus Pharmaceuticals [CRVS] share price is $5.94. The Score for CRVS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- CRVS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
55
Meituan (MPNGY)
is a Buy
Is Meituan a Buy, Sell or Hold?
- The current Meituan [MPNGY] share price is $48.14. The Score for MPNGY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- MPNGY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CRVS Stock Price Chart
What is Corvus Pharmaceuticals's stock price today?
-
The Corvus Pharmaceuticals share price today is $5.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
MPNGY Stock Price Chart
CRVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 67.4 | Buy |
| Chaikin Money Flow: | 290334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.55 - 5.69) | Buy |
| Bollinger Bands (100): | (1.9 - 4.58) | Buy |
MPNGY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.85 | Buy |
| Relative Strength Index (14 RSI): | 64.55 | Buy |
| Chaikin Money Flow: | 770328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.9 - 46.6) | Buy |
| Bollinger Bands (100): | (25.3 - 37.2) | Buy |
CRVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.39 | Buy |
| 20-day SMA: | 5.36 | Buy |
| 50-day SMA: | 4.41 | Buy |
| 200-day SMA: | 2.59 | Buy |
| 8-day EMA: | 5.49 | Buy |
| 20-day EMA: | 5.22 | Buy |
| 50-day EMA: | 4.47 | Buy |
| 200-day EMA: | 2.94 | Buy |
MPNGY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.08 | Sell |
| 20-day SMA: | 40.21 | Buy |
| 50-day SMA: | 32.92 | Buy |
| 200-day SMA: | 26.89 | Buy |
| 8-day EMA: | 48.84 | Sell |
| 20-day EMA: | 42.48 | Buy |
| 50-day EMA: | 36.01 | Buy |
| 200-day EMA: | 30.16 | Buy |
Corvus Pharmaceuticals Earnings Growth & CRVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and a decrease next year of $0.07 per share.
Meituan Earnings Growth & MPNGY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corvus Pharmaceuticals Technical Analysis
| Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Meituan Technical Analysis
| Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||